Buy me a coffee · $1
×

Support us with a small donation 💝

Every coffee keeps the site running. Thank you!

Commercial Deployment of Continuous Glucose Monitors Expands Beyond Diabetes Management

 ·  1 min read

Sales of continuous glucose monitoring (CGM) systems expanded 27% year-over-year as medical device manufacturers secure over-the-counter clearances and target broad wellness applications beyond classic type-1 and type-2 diabetes care.

Payer Coverage and Direct-to-Consumer Dynamics
While private insurance reimbursement remains contingent on clinical diagnosis, direct-to-consumer sales now account for 19% of total hardware revenues. Subscription pricing models averaging $80 to $120 monthly are demonstrating sustained subscriber retention rates above 60% after six months.

Data Integration and Preventive Care Metrics
Aggregate data from clinical trials indicates that real-time glucose visibility combined with algorithmic dietary feedback results in an average 0.4% reduction in HbA1c levels among pre-diabetic cohorts, prompting managed care organizations to evaluate preventive pilot coverage.